期刊文献+

重组人脑利钠肽对体外循环下心脏手术术后肾功能的影响 被引量:4

The effects of recombinant human brain natriuretic peptide on postoperative renal function in patients undergoing cardiac surgery with cardiopulmonary bypass
下载PDF
导出
摘要 目的探讨体外循环(CPB)下心脏手术围术期应用重组人脑利钠肽(rhBNP)对患者肾功能的影响。方法 33例行CPB下冠状动脉旁路移植术和瓣膜置换术患者随机分为观察组(A组,15例)与对照组(B组,18例)。A组为常规治疗基础上麻醉诱导后给予rhBNP治疗;B组为常规治疗。记录术前、术后0、8、24h血清肌酐(SCr)、肾小球滤过率(GFR);记录术前、术后N端脑钠肽原(NT-ProBNP)及尿量。结果术后24hB组Scr明显高于术前和A组,GFR明显低于术前和A组(P<0.05);术后B组NT-ProBNP明显高于术前和A组(P<0.05或P<0.01);术后24h尿量A组[(2275±145)ml]显著多于B组[(1927±267)ml](P<0.01)。结论 rhBNP能够改善CPB心脏手术患者术后早期肾功能。 Objective To determine the role of recombinant human brain natriuretic peptide (rhBNP) in postoperative renal function in patients undergoing cardiac surgery under cardiopulmonary bypass (CPB). Methods .Thirty three patients undergoing coronary artery bypass grafting and valve surgery were randomly divided into one of two groups: the testing group (group A, n=15) and the control group (group B, n=18). Group A received rhBNP for 24h after induction of anesthesia, but group B received conventional treatment. The 24 h levels of serum creatinine (SCr), glomerular filtration rate (GFR), N terminal pro-Brain natriuretic peptide (NT ProBNP), and urine output were recorded. Results Compared with the preoperative contents, the 24 h levels of SCr,GFR and NT-ProBNP changed significantly(P〈0.05) ; the 24 h urine output in the group A [(2 275 ± 145) ml] was more than the group B [(1927 ± 267) ml] (P〈0.01). Conclusion rhBNP can improve the early renal function of patients undergoing cardiac surgery.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2011年第3期264-266,共3页 Journal of Clinical Anesthesiology
关键词 重组人脑利钠肽 心脏手术 肾功能 Recombinant human brain natriuretic peptide Cardiac surgery Renal function
  • 相关文献

参考文献2

二级参考文献23

  • 1Nguyen MT, Ross GF, Dent CL, et al. Early prediction of acute renal injury using urinary proteomics[J]. Am J Nephrol, 2005,25(4) : 318-326.
  • 2Provenchere S, Plantefeve G, Hufnagel G, et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: incidence, risk factors, and effect on clinical outcome [ J ].Anesth Analg, 2003,96(5) : 1258-1264.
  • 3Mehta RL. Acute renal failure and cardiac surgery: marching in place or moving ahead? [J] J Am Soc Nephrol, 2005, 16( 1 ) :12-14.
  • 4Bove T, Calabroet MG, Landoni G, et al. The incidence and risk of acute renal failure after cardiac surgery[ J ]. J Cardiothorac Vasc Anesth, 2004, 18(4) : 442-445.
  • 5Chertow GM, Lazarus JM, Chfistiansen CL, et al. Preoperative renal risk stratification[J]. Circulation,1997,95(4) :878-884.
  • 6Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization : risk factors, adverse outcomes, and hospital resource utilization. The Muhicenter Study of Perioperative Ischemia Research Group [ J ]. Ann Intern Med,1998,128 ( 3 ) : 194 -203.
  • 7Meldrum DR, Donnahoo KK. Role of TNF in mediating renal insufficiency following cardiacsurgery: evidence of a postbypass cardiorenal syndrome[J]. J Surg Res,1999, 85(2) :185-199.
  • 8Risch L, Huber AR . Assessing glomerular filtration rate in renal transplant recipients by estimates derived from serum measurements of creatinine and cystatin[J]. Clin Chim Acta, 2005, 356(1-2) : 204-211.
  • 9Filler G, Lepage N. Should the schwartz formula for estimation of GFR be replaced by cystatin C formula? [J ] Pediatr Nephrol,2003, 18(10) : 981-985.
  • 10Xia LH, Bing XG, An XT. Serum cystatin C assay for the detection of early renal impairment in diabetic patients[J]. J Clin Lab Anal, 2004, 18( 1 ) : 31-35.

共引文献237

同被引文献25

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部